|
Volumn 77, Issue 6, 2002, Pages 435-441
|
The effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease
a a a a a a a a a a a a a a a |
Author keywords
Antituberculous drugs; CAM; MAC pulmonary disease; Treatment guideline
|
Indexed keywords
CLARITHROMYCIN;
ETHAMBUTOL;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ADULT;
AGED;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
FEMALE;
FEVER;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MYCOBACTERIUM INTRACELLULARE AVIUM;
PRACTICE GUIDELINE;
RELAPSE;
RETROSPECTIVE STUDY;
SKIN MANIFESTATION;
SPUTUM ANALYSIS;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VERTIGO;
VISUAL DISORDER;
ATYPICAL MYCOBACTERIOSIS;
DRUG COMBINATION;
MICROBIOLOGY;
MIDDLE AGED;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTITUBERCULAR AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
ENGLISH ABSTRACT;
FEMALE;
HUMAN;
LUNG DISEASES;
MALE;
MIDDLE AGE;
MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;
PRACTICE GUIDELINES;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
EID: 0036017922
PISSN: 00229776
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (13)
|